Monday, December 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Piper Sandler Analyst Maintains Overweight Rating on EPAM Systems with 369 Price Target

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
The Rise of Enterprise Business Intelligence Platforms: Transforming Operations in the Healthcare Sector
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Analyst Arvind Ramnani of Piper Sandler has once again expressed confidence in EPAM Systems (NYSE: EPAM), giving it an Overweight rating and sticking to a price target of $369. This latest show of support comes after Piper Sandler previously upgraded their view on EPAM Systems from Neutral to Overweight on November 2, 2023, raised the price target from $265 to $339 on January 4, 2024, and then bumped it up to $369 on February 15, 2024. These consistent endorsements and price target adjustments signal Piper Sandler’s optimistic stance on EPAM Systems.

Date: March 4, 2024

EPAM Systems, Inc. Stock Soars on Strong Performance – March 4, 2024

On March 4, 2024, EPAM Systems, Inc. (EPAM) showed strong performance in the stock market as it traded near the top of its 52-week range and above its 200-day simple moving average. According to data from CNN Money, EPAM shares saw a price increase of $2.43 on March 4, 2024, closing at $306.83. This represents a 0.80% rise in the stock price from the previous trading day. EPAM is a leading global provider of digital platform engineering and software development services. Investors are likely optimistic about EPAM’s future prospects, given its strong performance in the stock market. Overall, EPAM’s stock performance on March 4, 2024, reflects the company’s strong fundamentals and positive outlook. EPAM’s stock is definitely one to watch for investors looking for opportunities in the technology sector.

EPAM Systems, Inc. Reports Flat Financial Performance for 2023 – SEO Title

On March 4, 2024, EPAM Systems, Inc. (EPAM) reported its financial performance for the past year and the fourth quarter. According to data from CNN Money, the company’s total revenue for the past year was $4.69 billion, which remained flat compared to the previous year. Similarly, the total revenue for the fourth quarter was $1.16 billion, holding steady since the previous quarter.

EPAM’s net income for the past year was reported at $417.08 million, which also remained flat compared to the previous year. The net income for the fourth quarter was $97.55 million, holding steady since the previous quarter.

Earnings per share (EPS) for the past year was reported at $7.06, which remained flat compared to the previous year. The EPS for the fourth quarter was $1.66, holding steady since the previous quarter.

Overall, EPAM’s financial performance on March 4, 2024, showed that the company’s total revenue, net income, and earnings per share remained flat since the previous year and the previous quarter. This suggests that the company’s financial stability and performance have been consistent over the past year.

Tags: EPAM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
CRWD stock news

Analyst Bullish on Ciena with Increased Price Target

Finance_Commercial

Wells Fargo Upgrades Price Target for CrowdStrike Holdings Expresses Bullish Stance

Tech-banking-finance

Analyst Reaffirms Buy Rating for Geron with 4 Price Target

Recommended

Ocugen Stock

Ocugen’s Financial Race Against Time

1 month ago
Citizens Stock

Citizens Financial Group: A Study in Market Contradictions

4 months ago
Asbury Automotive Stock

Mixed Signals Emerge as Asbury Automotive Posts Record Earnings

3 months ago
Intellia Therapeutics Stock

Intellia Therapeutics Emerges as Gene Editing Front-Runner with Accelerated Trial Progress

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

IonQ Secures Major European Contract Extension Valued at Over $60 Million

Lynas Gains Market Favor with Key Index Inclusion Amid Operational Hurdles

Adobe’s Strategic Countermove in the AI Video Arena

Alphabet’s AI Strategy Gains Momentum with New Model and Major Deals

Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push

Wolfspeed Secures Financial and Strategic Milestones

Trending

Hims & Hers Stock
Healthcare

Hims & Hers Charts North American Growth with Canadian Market Entry

by Robert Sasse
December 22, 2025
0

The telehealth provider Hims & Hers Health is accelerating its international strategy with a decisive move into...

ServiceNow Stock

ServiceNow Shares Navigate Post-Split Turbulence Amid Acquisition Talks

December 22, 2025
Pfizer Stock

Pfizer Shares Face a Multifaceted Squeeze

December 22, 2025
IonQ Stock

IonQ Secures Major European Contract Extension Valued at Over $60 Million

December 22, 2025
Lynas Stock

Lynas Gains Market Favor with Key Index Inclusion Amid Operational Hurdles

December 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Hims & Hers Charts North American Growth with Canadian Market Entry
  • ServiceNow Shares Navigate Post-Split Turbulence Amid Acquisition Talks
  • Pfizer Shares Face a Multifaceted Squeeze

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com